Last reviewed · How we verify
NCT04686513
Relative Risk of Hypertension Among Obese
trial testing Observation in Obesity in 1,149 participants. Completed in 30 November 2020.
2 November 2020
Quick facts
| Lead sponsor | Ziauddin University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,149 |
| Start date | 10 October 2019 |
| Primary completion | 2 November 2020 |
| Estimated completion | 30 November 2020 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Observation
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Ziauddin University
Who can join
Adults 25 to 40, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Observational study was conducted to determine the relative risk of hypertension among young adult obese population of Pakistan with age between 25-40 years
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04686513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation
Trials testing the same drug.
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
- NCT07563088 — SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Ziauddin University trials
Trials by the same sponsor.
- NCT07325981 — Effect of Biofeedback-Enhanced Exergaming, Exergaming Alone, and Traditional Physical Therapy on Motor Function, Adheren · NA · not yet recruiting
- NCT06871904 — Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis · Phase 1, PHASE2 · completed
- NCT07097441 — To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With · Phase 1, PHASE2 · completed
- NCT07232316 — Effect of Integrated Neuromuscular Inhibition Technique on Scapular Dyskinesia Type 2 · NA · completed
- NCT07079514 — Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04686513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziauddin University
- Last refreshed: 28 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04686513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing